search
Back to results

Norepinephrine or Phenylephrine in Bolus for Hypotension in Cesarean Delivery

Primary Purpose

Hypotension, Spinal Anesthesia

Status
Completed
Phase
Phase 2
Locations
Brazil
Study Type
Interventional
Intervention
Phenylephrine 100 mcg
Norepinephrine 5 mcg
Sponsored by
Hospital dos Servidores do Estado do Rio de Janeiro
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypotension focused on measuring phenylephrine, norepinephrine, cesarean delivery under spinal anesthesia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Pregnant women, with single gestation, with cesarean programming to be performed under spinal anesthesia;
  • Age above 18 years;
  • Physical State American Society of Anesthesiologists (ASA) II and III;
  • Weight between 50kg and 120kg;
  • Height between 140cm and 180cm.

Exclusion Criteria:

  • Refusal to participate in the study;
  • Pregnant women with fetus with known abnormalities;
  • Pregnant women with cardiovascular disease;
  • Pregnant women with pregnancy-specific hypertensive disease;
  • Allergy to any medication to be used in the study;
  • Users of monoamine oxidase inhibitors;
  • Users of tricyclic antidepressants;
  • Emergency caesarean section due to acute fetal distress;
  • Situations in which the sensory level after single intrathecal injection of the local anesthetic does not reach at least T6 within 5 minutes after spinal anesthesia.

Sites / Locations

  • Hospital Federal Dos Servidores Do Estado

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Phenylephrine 100 mcg

Norepinephrine 5 mcg

Arm Description

Phenylephrine will be used at a dose of 100 mcg bolus at a dilution containing 20 mcg / mL of the drug to be used whenever systolic blood pressure falls below 10% of baseline.

Norepinephrine will be used at a dose of 5 mcg at a dilution containing 1 mcg / mL to be used whenever systolic blood pressure falls below 10% of baseline.

Outcomes

Primary Outcome Measures

Number of bolus required
Number of bolus doses of phenylephrine and noradrenaline to maintain systemic arterial pressure at 90% of baseline in pregnant women undergoing spinal anesthesia for cesarean
Heart rate
Number of episodes of heart rate under 60 bpm while using phenylephrine and noradrenaline in pregnant women undergoing spinal anesthesia for cesarean

Secondary Outcome Measures

Neonatal gasometric outcome
To evaluate the neonatal outcome through the analysis of venous and arterial blood gases collected in the cord umbilical after birth.
Neonatal Apgar outcome
To evaluate the neonatal outcome through the classification given by the neonatologist responsible for the care to the newborn in the delivery room with the use of the Apgar Scale (0-10), 10 the better classification.
Nausea and vomiting
To evaluate the incidence of nausea and vomiting of the parturient during cesarean section

Full Information

First Posted
October 6, 2018
Last Updated
April 8, 2021
Sponsor
Hospital dos Servidores do Estado do Rio de Janeiro
search

1. Study Identification

Unique Protocol Identification Number
NCT03702400
Brief Title
Norepinephrine or Phenylephrine in Bolus for Hypotension in Cesarean Delivery
Official Title
Randomized Double-blinded Comparison of Norepinephrine and Phenylephrine in Bolus for Maintenance of Blood Pressure During Spinal Anesthesia for Cesarean Delivery
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
October 1, 2018 (Actual)
Primary Completion Date
June 1, 2020 (Actual)
Study Completion Date
October 1, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital dos Servidores do Estado do Rio de Janeiro

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study evaluate the ability of phenylephrine and of noradrenaline to maintain normal systemic arterial blood pressure and heart rate in healthy pregnant women submitted to cesarean section with spinal anesthesia. Half of participants will receive bolus of phenylephrine while the other half will receive bolus of noradrenaline.
Detailed Description
This is a prospective, randomized, double-blind, comparative two-group clinical study to observe two vasopressor drugs, phenylephrine and noradrenaline, in the ability to maintain systemic arterial pressure in pregnant women after spinal anesthesia for cesarean section; based on the hypothesis that, since noradrenaline has a predominant alpha-adrenergic action and a weak 1- beta-adrenergic beta action, it could be as capable of maintaining blood pressure effectively as phenylephrine, but with a lower frequency of bradycardia; patients who meet the inclusion criteria will be randomly assigned to one of the groups to be studied: group F - phenylephrine at a dose of 100mcg bolus and N - noradrenaline at the dose of 5mcg. One of these drugs will be used whenever systolic blood pressure drops below 10% of the baseline, additional doses will be allowed whenever necessary, aiming at maintaining the systolic blood pressure at baseline values; the blood pressure will be measured non-invasively and the heart rate by pulse oximeter and electrocardiogram.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypotension, Spinal Anesthesia
Keywords
phenylephrine, norepinephrine, cesarean delivery under spinal anesthesia

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
In a randomized, double-blinded study, 76 healthy patients having cesarean delivery under spinal anesthesia will be randomized, using an electronic system (the Randomizer App®, Version 3.2 Wisse Keizer program), to have systolic blood pressure maintained with bolus of phenylephrine at a dose of 100 mcg bolus (at a dilution containing 20 mcg / mL), or with norepinephrine at a dose of 5 mcg (at a dilution containing 1 mcg / mL).
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
72 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Phenylephrine 100 mcg
Arm Type
Active Comparator
Arm Description
Phenylephrine will be used at a dose of 100 mcg bolus at a dilution containing 20 mcg / mL of the drug to be used whenever systolic blood pressure falls below 10% of baseline.
Arm Title
Norepinephrine 5 mcg
Arm Type
Experimental
Arm Description
Norepinephrine will be used at a dose of 5 mcg at a dilution containing 1 mcg / mL to be used whenever systolic blood pressure falls below 10% of baseline.
Intervention Type
Drug
Intervention Name(s)
Phenylephrine 100 mcg
Other Intervention Name(s)
Fenilefrin
Intervention Description
Phenylephrine at a dose of 100 mcg bolus at a dilution containing 20 mcg / mL of the drug, 5 mL each bolus
Intervention Type
Drug
Intervention Name(s)
Norepinephrine 5 mcg
Other Intervention Name(s)
Hemitartarato de norepinefrina
Intervention Description
Norepinephrine at a dose of 5 mcg at dilution containing 1 mcg / mL, 5 mL each bolus
Primary Outcome Measure Information:
Title
Number of bolus required
Description
Number of bolus doses of phenylephrine and noradrenaline to maintain systemic arterial pressure at 90% of baseline in pregnant women undergoing spinal anesthesia for cesarean
Time Frame
during the procedure
Title
Heart rate
Description
Number of episodes of heart rate under 60 bpm while using phenylephrine and noradrenaline in pregnant women undergoing spinal anesthesia for cesarean
Time Frame
during the procedure
Secondary Outcome Measure Information:
Title
Neonatal gasometric outcome
Description
To evaluate the neonatal outcome through the analysis of venous and arterial blood gases collected in the cord umbilical after birth.
Time Frame
during the procedure
Title
Neonatal Apgar outcome
Description
To evaluate the neonatal outcome through the classification given by the neonatologist responsible for the care to the newborn in the delivery room with the use of the Apgar Scale (0-10), 10 the better classification.
Time Frame
during the procedure
Title
Nausea and vomiting
Description
To evaluate the incidence of nausea and vomiting of the parturient during cesarean section
Time Frame
during the procedure

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Pregnant women, with single gestation, with cesarean programming to be performed under spinal anesthesia; Age above 18 years; Physical State American Society of Anesthesiologists (ASA) II and III; Weight between 50kg and 120kg; Height between 140cm and 180cm. Exclusion Criteria: Refusal to participate in the study; Pregnant women with fetus with known abnormalities; Pregnant women with cardiovascular disease; Pregnant women with pregnancy-specific hypertensive disease; Allergy to any medication to be used in the study; Users of monoamine oxidase inhibitors; Users of tricyclic antidepressants; Emergency caesarean section due to acute fetal distress; Situations in which the sensory level after single intrathecal injection of the local anesthetic does not reach at least T6 within 5 minutes after spinal anesthesia.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
DANIEL V DE QUEIROZ
Organizational Affiliation
HOSPITAL FEDERAL DOS SERVIDORES DO ESTADO
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Federal Dos Servidores Do Estado
City
Rio De Janeiro
State/Province
RJ
ZIP/Postal Code
22451-030
Country
Brazil

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
25635593
Citation
Ngan Kee WD, Lee SW, Ng FF, Tan PE, Khaw KS. Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery. Anesthesiology. 2015 Apr;122(4):736-45. doi: 10.1097/ALN.0000000000000601.
Results Reference
background
PubMed Identifier
27720613
Citation
Vallejo MC, Attaallah AF, Elzamzamy OM, Cifarelli DT, Phelps AL, Hobbs GR, Shapiro RE, Ranganathan P. An open-label randomized controlled clinical trial for comparison of continuous phenylephrine versus norepinephrine infusion in prevention of spinal hypotension during cesarean delivery. Int J Obstet Anesth. 2017 Feb;29:18-25. doi: 10.1016/j.ijoa.2016.08.005. Epub 2016 Aug 28.
Results Reference
background

Learn more about this trial

Norepinephrine or Phenylephrine in Bolus for Hypotension in Cesarean Delivery

We'll reach out to this number within 24 hrs